Imagine having a window into your own body — before you’re sick or symptomatic enough to warrant an MRI from your doctor.
Andrew Lacy is the founder and CEO of Prenuvo, a health tech company specializing in proactive whole-body diagnostic imaging. He chats with Dr. Anthony Gustin about patient-driven early detection of cancer and other major health issues.
Despite following the best wellness routine, most of us don’t have a black-and-white picture of how our lifestyle will affect our health trajectory over the next 10 or even 20 years.
Uncovering this data could be our catalyst for change.
It may empower us to make more informed decisions to advocate for our long-term wellness. It may change our “I feel good today, so why worry” mindset. And it may even help us catch early signs of cancer at stage 1 instead of suffering the devastating shock at stage 4.
Dr. Gustin and his wife recently went for Prenuvo scans, which you’ll hear about during the episode. He and Andrew also discuss:
The perfect candidates for proactive screens.
The general flow of how the screening process works.
The importance of early detection for everything from cancer and aneurysms to back problems and issues caused by chronic metabolic disorders.
The pros and cons of different imaging processes (CT vs. MRI vs. X-ray).
What can/cannot be detected, and the most commonly detected conditions.
The advantages and challenges of using AI in imaging analysis.
Where insurance companies stand on preventative scans now and in the future.
Using your scan data as a catalyst for taking better care of your health.
Resources mentioned in this episode:
Andrew Lacy’s Prenuvo (visit Prenuvo.com/AG for $300 off your Whole-Body scan)
Andrew’s Twitter
The Johns Hopkins pancreatic cancer study Andrew mentioned
